myeloproliferative neoplasm, unclassifiable
Showing 1 - 5 of 5
Epidemiological and Clinical-pathological Factors of
Completed
- Myeloproliferative Neoplasm
- +4 more
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 25, 2023
Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Decitabine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 18, 2022
National Center for Precision Medicine in Leukemia
Not yet recruiting
- Acute Myeloid Leukemia
- +4 more
- Biobanking
- (no location specified)
Jun 7, 2022
MPN Podcast Pilot Study
Completed
- Myeloproliferative Neoplasm, Unclassifiable
-
Phoenix, ArizonaArizona State University
Mar 26, 2020
Myeloproliferative Tumor, Unclassifiable, Essential Thrombocythemia, Myelofibrosis Trial in Herlev (CALRLong36 peptide)
Unknown status
- Myeloproliferative Neoplasm, Unclassifiable
- +2 more
- CALRLong36 peptide
-
Herlev, Capital Region, DenmarkHerlev Hospital
Feb 14, 2019